E
Aurora Spine Corporation ASG.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income 15.50% 40.34% 71.56% 54.48% 27.75%
Total Depreciation and Amortization -13.12% -3.98% -5.32% 10.46% 19.90%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -23.94% -13.01% -27.43% -28.23% -20.09%
Change in Net Operating Assets 212.02% 200.35% -274.48% -276.25% -134.03%
Cash from Operations 282.97% 196.72% 45.40% -7.65% 32.32%
Capital Expenditure 35.69% 14.74% 15.25% -55.30% 17.01%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 22.70% -1.09% 30.68% -24.00% 27.95%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -23.58% -14.02% -2.35% 33.50% 30.61%
Issuance of Common Stock -95.52% -- 67.87% 67.87% 67.87%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -130.30% -120.55% 91.92% 158.83% 159.21%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 2,495.74% -82.88% 287.47% 135.42% 100.44%